KORU Medical Systems (KRMD): Market Capitalization-to-Revenue Ratio

Symbol and logo of brand KORU Medical Systems (KRMD)

KORU Medical Systems dominates the home infusion systems segment due to stringent licensing barriers. Comfortable therapy devices ensure high user confidence. The price-to-sales multiple exhibits a prolonged sideways trend, where 3.70 becomes the new value of the indicator. The business's profit is based on a consumables sales model, which allows the company to exercise independent pricing power.

Price-to-Revenue Ratio: KORU Medical Systems, Inc. (KRMD) for 07/04/2022 - 11/13/2026

Metric breakdowns and analytics for KORU Medical Systems (KRMD)

- stock quotes and analyst forecast:
Price korumedical.com|KRMD - Price Target Chart
- stock exchange capitalization data:
Market Value KORU Medical Systems Inc.|KRMD - Real Price to Acquire Entire Company
- book capitalization indicators:
Book Value per Share KORU Medical Systems|KRMD - Company Book Value|Market Cap to Net Assets Ratio korumedical.com|KRMD - Company Total Assets
- business debt structure and liquidity details:
Debt to Capital KORU Medical Systems|KRMD - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio korumedical.com|KRMD - Company Total Debt|Debt to Book Capital KORU Medical Systems Inc.|KRMD - Company Long-Term Debt|Short-Term Debt Volume KORU Medical Systems|Quick Ratio korumedical.com
- company profitability and valuation multiples indicators:
KRMD - Company Net Income|Expected Net Profit KORU Medical Systems|KRMD - Price to Earnings Ratio|Future Price to Earnings Multiple korumedical.com|KRMD - Price/Earnings to Growth Multiple|EV/EBITDA Multiple KORU Medical Systems Inc.|KRMD - Operating profit before deduction of amortization|Earnings per share for the trailing year KORU Medical Systems|KRMD - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months korumedical.com|KRMD - Earnings growth in current year|Expected net earnings per share growth next year KORU Medical Systems
- total revenue and sales volume data:
KRMD - Revenue and Sales Volume|Company Revenue Forecast korumedical.com|KRMD - P/S Multiple|Market Cap to Expected Sales Ratio KORU Medical Systems Inc.
Summary company analytics:KORU Medical Systems, Inc.
Mass-produced product of KORU Medical Systems, Inc.

The ratio of market capitalization to annual revenue determines the growth premium, with the current value of 3.70 reflecting the market valuation of every dollar of KORU Medical Systems (KRMD) sales. By analyzing the company's price/sales multiple, an investor assesses monetization efficiency, which in this case is supported by minimizing logistical risks and the strategic stockpiling of critical components to ensure uninterrupted system production.

Competitors of KORU Medical Systems

Market Cap to Sales Volume ISRG|Price-to-Revenue Ratio Danaher DHR|Market Capitalization-to-Revenue Ratio BDX|STE: Market Cap to Revenue|WST - P/S Multiple|Baxter International (BAX) - Price-to-Revenue Ratio|Market Cap to Revenue masimo.com|STVN (Stevanato Group) - P/S Multiple|Price to Sales Teleflex Inc. TFX|Price-to-Revenue Ratio Merit Medical Systems Inc (MMSI)|Nobel Biocare - Market Cap to Revenue Ratio|ICU Medical, Inc. - Market Cap to Revenue|Market Cap to Sales Volume XRAY (dentsplysirona.com)|LMAT - Price-to-Revenue Ratio|Price-to-Revenue Coefficient AtriCure Inc ATRC|STAAR Surgical Corp (STAA) - Price-to-Revenue Ratio|Niagen (NAGE) - P/S Multiple|Price-to-Revenue Ratio ZimVie Inc.|Price to Sales angiodynamics.com ANGO|Price-to-Revenue Ratio Cerus (CERS)|TKNO (Alpha Teknova) - Market Capitalization-to-Revenue Ratio|Monogram Technologies Inc - Market Cap to Revenue|P/S Multiple Sharps Technology Inc STSS|INFU: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio UTMD (utahmed.com)|Nyxoah (NYXH) - Price-to-Revenue Ratio|Market Cap to Revenue Microbot Medical, Inc.|PDEX (Pro-Dex Corp) - P/S Multiple|Price to Sales Zentek Corp ZTEK|P/S Multiple ELUT|milestonescientific.com - Market Cap to Revenue Ratio|P/S Multiple NXGL (NEXGEL)|Price-to-Revenue Coefficient Retractable Technologies Inc. (RVP)|Harvard Bioscience - P/S Multiple|Femasys Corporation (FEMY) - Market Cap to Revenue|MHUA: P/S Multiple|Predictive Oncology Inc. (POAI) - P/S Multiple|Price-to-Revenue Ratio Callan JMB Inc.|Price-to-Revenue Ratio ATRI|Market Cap to Revenue NURO (NeuroMetrix Corp)